Argatroban

From WikiMD.org
Jump to navigation Jump to search

Argatroban

Argatroban (pronounced: ar-GAT-ro-ban) is a type of anticoagulant medication, specifically a direct thrombin inhibitor. It is primarily used to treat or prevent thrombosis in patients with heparin-induced thrombocytopenia (HIT).

Etymology

The name "Argatroban" is derived from its chemical structure. The "Arga" part of the name comes from the arginine derivative, while the "troban" part is a common suffix for thrombin inhibitors.

Usage

Argatroban is used as an anticoagulant for patients who have developed HIT. HIT is a condition where the body's immune system mistakenly attacks platelets in the blood after exposure to heparin, leading to a high risk of blood clots. Argatroban works by directly inhibiting thrombin, an enzyme that plays a crucial role in blood clotting.

Dosage and Administration

Argatroban is administered intravenously. The dosage is adjusted based on the patient's activated partial thromboplastin time (aPTT), a measure of the blood's ability to clot. The goal is to maintain the aPTT at 1.5 to 3 times the initial value.

Side Effects

Common side effects of Argatroban include bleeding, headache, fever, and back pain. Serious side effects can include major bleeding events, allergic reactions, and liver problems.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski